Medicinal Cannabis Matters: Friday Roundup - 30 October 2026

Cannabis Health Symposium Returns to Discuss Patient Access and Rights

The Cannabis Health Symposium is returning to bring together clinicians, researchers, regulators and patient advocates to discuss the challenges facing medicinal cannabis patients.

As reported by Leafie, the event will explore topics including access to treatment, workplace rights, interactions with the police and the role of real-world patient experiences in shaping clinical understanding.

For patients, access to treatment is only one part of the journey. Clear information about their rights, appropriate clinical support and confidence in their treatment are equally important. Discussions like these can help identify barriers to care and encourage better understanding between patients and healthcare professionals.

Building a more accessible treatment pathway also means maintaining appropriate prescribing standards and ensuring patients receive personalised advice and ongoing support.

The Future of Pain Medicine and Medicinal Cannabis

Chronic pain can affect every aspect of daily life, from sleep and mobility to relationships and emotional wellbeing. In a new interview with Cannabis Health, pain specialist Dr Michael Überall discusses emerging evidence for cannabinoid medicines and their potential role in pain management.

The interview explores research into VER-01, a standardised cannabinoid medicine investigated for chronic low back pain. Clinical studies have reported improvements in pain and other outcomes, including sleep and physical functioning, offering an area of interest for further research.

The discussion also highlights the importance of looking beyond pain scores alone. For people living with chronic pain, improvements in sleep, mobility and everyday activities can be just as meaningful as a reduction in pain intensity.

Legal Medicinal Cannabis and the Importance of Health Protection

In an article for Business of Cannabis, Dr Julian Wichmann argues that legal access to medicinal cannabis can support patient safety rather than weaken health protection. The discussion focuses on Germany, where proposed changes to prescribing and access have prompted debate about the right balance between regulation and availability.

The article highlights the distinction between prescribed, pharmacy-supplied medicines and products obtained through unregulated channels. Appropriate clinical direction can help patients understand potential benefits, side effects and interactions with other medicines, while reliable product standards provide greater assurance about what they are receiving.

However, legal access does not automatically mean a treatment is suitable for everyone. Medicinal cannabis still requires careful assessment, and further evidence is needed to understand its effectiveness for different conditions.

The wider challenge is ensuring regulation protects patients while allowing appropriate access to treatment, supported by clinical judgement and ongoing research.

Medicinal Cannabis and the Menstrual Cycle

Could hormonal changes throughout the menstrual cycle influence how patients respond to medicinal cannabis? This is the question explored in a new Cannabis Health article by Nicole Farah, which considers the potential implications for prescribing.

The endocannabinoid system is involved in several bodily processes, and research suggests links between endocannabinoid signalling and reproductive health. This has prompted interest in whether hormonal fluctuations could affect symptoms such as pain, sleep disturbance and mood, or influence responses to cannabinoid medicines.

Further research that reflects women's experiences could help clinicians better understand symptom patterns and individual treatment responses. For now, patients should discuss any changes in symptoms or concerns about their medication with their prescribing doctor rather than adjusting treatment themselves.

While new findings offer areas for further investigation, treatment decisions should always be guided by the available evidence and an individual's circumstances. At Medicann, we believe patients deserve clear information, specialist guidance and ongoing support throughout their treatment journey.

If you would like to explore whether medicinal cannabis may be suitable for you, start with our online eligibility checker.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.